Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Severe Disruptive Behaviour Disorders: early-phase trial registry

1 of 1 indexed Severe Disruptive Behaviour Disorders trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Severe Disruptive Behaviour Disorders: 1 US clinical trial tracked, 1 recruiting.

Severe Disruptive Behaviour Disorders is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Jeremy Veenstra-vanderweele, running 1 of these trials.

Enrollment posture brief

Registry condition severe-disruptive-behaviour-disorders

OPEN 1 | RECR 100% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Severe Disruptive Behavi (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Severe Disruptive Behaviour Disorders

Severe Disruptive Behaviour Disorders lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Severe Disruptive Behaviour Disorders on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Severe Disruptive Behaviour Disorders is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Top Sponsors

Named interventions

Most-linked intervention names on Severe Disruptive Behaviour Disorders records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Propranolol Drug
1 trials
Placebo Drug
1 trials

US sites by state

Facility locations filed on Severe Disruptive Behaviour Disorders trials. A trial with sites in several states counts in each.

New York 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Severe Disruptive Behaviour Disorders page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Severe Disruptive Behaviour Disorders trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Jeremy Veenstra-vanderweele sponsors the most Severe Disruptive Behaviour Disorders trials on record, review their full trial history before evaluating a specific study. See Jeremy Veenstra-vanderweele's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Severe Disruptive Behaviour Disorders condition card totals 1 registered trials; most-linked intervention Propranolol; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.